LILLY TUNELAB

Serial Number 98941907
686

Registration Progress

Application Filed
Jan 7, 2025
Under Examination
Approved for Publication
Jun 10, 2025
Published for Opposition
Jun 10, 2025
Registered

Basic Information

Serial Number
98941907
Filing Date
January 7, 2025
Published for Opposition
June 10, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jun 10, 2025
Application
Pending
Classes
042 044

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom
USPTO Deadlines 2 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
EXAMINER AMENDMENT
Examiner's Amendment Completed
CNEA May 23, 2025 45 days overdue Low No
OPPOSITION
Notice of Publication
NPUB Jul 10, 2025 3 days Medium Until Aug 10, 2025
Next deadline: Notice of Publication on July 10, 2025 (3 days)

Application History

11 events
Date Code Type Description
Jun 10, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 10, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jun 4, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN
May 8, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 8, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED
May 8, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED
May 2, 2025 DOCK D ASSIGNED TO EXAMINER
Apr 29, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Product development; Pharmaceutical products development; Biological product development services; Research and development services in the field of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Scientific research and development; Pharmaceutical product evaluation during product development; Scientific research consulting; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Compiling data for research purposes in the field of medical science and pharmaceutical drug development
Class 044
Medical information; Medical analysis for the diagnosis and treatment of persons

Additional Information

Pseudo Mark
LILLY TUNE LAB

Classification

International Classes
042 044